Welcome to LookChem.com Sign In|Join Free
  • or
6-Bromo-4'-hydroxyflavone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

288401-01-4

Post Buying Request

288401-01-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

288401-01-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 288401-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,8,4,0 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 288401-01:
(8*2)+(7*8)+(6*8)+(5*4)+(4*0)+(3*1)+(2*0)+(1*1)=144
144 % 10 = 4
So 288401-01-4 is a valid CAS Registry Number.

288401-01-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-2-(4-hydroxyphenyl)chromen-4-one

1.2 Other means of identification

Product number -
Other names 6-BROMO-4'-HYDROXYFLAVONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:288401-01-4 SDS

288401-01-4Relevant academic research and scientific papers

Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters

Dankó, Balázs,Tóth, Szilárd,Martins, Ana,Vágv?lgyi, Máté,Kúsz, Norbert,Molnár, Joseph,Chang, Fang-Rong,Wu, Yang-Chang,Szakács, Gergely,Hunyadi, Attila

, p. 850 - 859 (2017/06/13)

There is a constant need for new therapies against multidrug-resistant (MDR) cancer. Natural compounds are a promising source of novel anticancer agents. We recently showed that protoflavones display activity in MDR cancer cell lines that overexpress the P-glycoprotein (P-gp) drug efflux pump. In this study, 52 protoflavones, including 22 new derivatives, were synthesized and tested against a panel of drug-sensitive parental cells and their MDR derivatives obtained by transfection with the human ABCB1 or ABCG2 genes, or by adaptation to chemotherapeutics. With the exception of protoapigenone, identified as a weak ABCG2 substrate, all protoflavones bypass resistance conferred by these two transporters. The majority of the compounds were found to exhibit mild to strong (up to 13-fold) selectivity against the MCF-7Dox and KB-V1 cell lines, but not to transfected MDR cells engineered to overexpress the MDR transporters. Our results suggest that protoflavones can overcome MDR cancer by evading P-gp-mediated efflux.

COMPOSITION FOR AMYLOID-ASSOCIATED DISEASE DIAGNOSIS

-

Page/Page column 5; 34; 44; 52, (2010/11/28)

A composition for diagnosing amyloid-related diseases, which comprises a flavone derivative, a chalcone derivative, a styrylchromone derivative, or a coumarin derivative, is provided. These compounds have high binding specificity to an amyloid β protein,

Radioiodinated flavones for in vivo imaging of β-amyloid plaques in the brain

Ono, Masahiro,Yoshida, Naoko,Ishibashi, Kenichi,Haratake, Mamoru,Arano, Yasushi,Mori, Hiroshi,Nakayama, Morio

, p. 7253 - 7260 (2007/10/03)

In vivo imaging of β-amyloid (Aβ) peptide aggregates in the brain may lead to early detection of Alzheimer's disease (AD) and monitoring of the progression and effectiveness of AD treatment. The purpose of this study was to develop novel amyloid imaging a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 288401-01-4